Sponsored by AnteAGE
The business of growing hair in aesthetics includes a synergy of treatments that incorporate transdermal technologies with advanced topical therapies. Exosomes have emerged as an option to aid in hair growth treatment, but it is often difficult to predict reliable outcomes. 
Unhappy with a one-size-fits-all approach to exosomes for hair, AnteAGE (Irvine, Calif.) has developed a specific formulation for hair growth.
“Multiple studies have shown the benefits for hair growth with platelet-rich plasma (PRP) injections,” explained board-certified dermatologist Arash Akhavan, MD (New York, N.Y.). “As with many other physicians, we sometimes find the procedure to be less effective than expected and believe the variability in efficacy may be due to individual growth factor makeup.”
“AnteAGE MDX Exosome Hair Solution® was designed specifically with growth factors that are powerful signaling molecules for hair,” Dr. Akhavan continued. “When applied to the scalp, they help to create a favorable environment for hair follicles by enhancing cellular repair, reducing inflammation and promoting growth of dermal papilla cells, which are key in the hair growth cycle.”
The standard exosomes in AnteAGE products, secreted from bone marrow- and umbilical cordderived stem cells, are effective for general skin rejuvenation but may not provide the specialized signaling required for optimal hair regeneration. To increase the effectiveness of the traditional approach, AnteAGE hair exosomes are treated with a wingless-related integration site (Wnt) signaling modulator during production, which plays an important role in regulating hair growth and follicle development.
According to Dr. Akhavan, AnteAGE hair exosomes offer a comprehensive approach to address the various causes of hair thinning, including hormonal imbalances, genetics and environmental factors, leading to improved hair density, thickness and overall scalp health. He added that they are also proven effective for both women and men experiencing various forms of hair thinning and loss, including androgenetic alopecia and telogen effluvium.
Adrian House, MD, a facial plastic surgeon in Menlo Park, Calif., reported that hair loss is a major concern for many of his patients. “I predominantly treat men aged 30 to 50 and women aged 40 to 60 who are experiencing early stages of hair thinning,” he stated. “The AnteAGE MDX Exosome Hair Solution has shown remarkable results in these demographics, with patients observing significant improvements in hair density and overall scalp health.”
Dr. House shared that he frequently combines the AnteAGE hair solution with microneedling and may incorporate low-level laser therapy (LLLT) to further activate the hair follicles and enhance treatment outcomes. “One of my gold standard protocols involves a three-step process,” he explained. “Initially, I perform microneedling on the scalp to create micro-channels. Following this, I apply the AnteAGE MDX Exosome Hair Solution, ensuring comprehensive coverage of the treated area, then patients leave with a Home Hair System kit for daily use until their next treatment. This protocol, typically repeated every four to six weeks for three to four sessions, has consistently delivered excellent results, with patients noticing substantial improvements in hair density and quality.
“Incorporating the AnteAGE MDX Exosome Hair Solution offers a cutting-edge, scientifically backed treatment for hair restoration that consistently yields impressive results,” Dr. House concluded. “This solution has helped differentiate my practice by providing an advanced option that complements other aesthetic services I offer, leading to higher patient satisfaction and retention.”
